News & Analysis as of

Substance Abuse

Relaxation of SAMHSA laws intended to align with advances in health care delivery

by Thompson Coburn LLP on

The final rule governing changes to the Substance Abuse and Mental Health Services Administration (SAMHSA) regulations became effective February 2, 2018. What is SAMHSA? The federal SAMHSA regulations (42 CFR Part 2)...more

Big Pharma firm, under fire in drug abuse epidemic, scales back opioid’s hype

Purdue Pharma, which built a multi-billion-dollar family empire, in part, by overcoming doctors’ resistance to prescribing powerful painkillers like its own powerhouse OxyContin, has decided to curb its quarter-century of...more

CMS Considers 7-Day Limit on Initial Opioid Prescriptions under Part D

In a Draft Call Letter issued February 1, 2018, the Centers for Medicare & Medicaid Services (CMS) announced that it is considering a number of new strategies to address opioid overutilization within the Medicare Part D...more

Alston & Bird Healthcare Week In Review

by Alston & Bird on

On January 29, 2018, the Centers for Medicare and Medicaid Services (CMS) issued a notice entitled, Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of the Extension of Temporary Moratoria on...more

Opioid Epidemic Spurs Increase in Drug Testing, Risks for Employers

by Ballard Spahr LLP on

The Department of Transportation (DOT) recently added four drugs at the heart of the nation's opioid epidemic to its drug testing panels: hydrocodone, hydromorphone, oxycodone and oxymorphone—the central ingredients in such...more

SAMHSA Updates Privacy Regulations to Reflect Advancements in Healthcare

by BakerHostetler on

On Jan. 3, 2018, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued its final rule regarding the Confidentiality of Substance Use Disorder Patient Records Part 2. These changes become effective Feb....more

Opioid Crisis Hits Flat Note with Another Celebrity Death Caused by Overdose

Epidemic Costs Country Billions Each Year, Leading Government Entities To Sue Big Pharma - Beloved singer Tom Petty became part of America’s opioid crisis when it was revealed that the 66-year-old’s cause of death in Oct....more

News from Second & State

Weekly Wrap - Both the House of Representatives and Senate were in Harrisburg this week for session for the first time in 2018. The new year kicked off on Monday with a joint public hearing of the House and Senate Local...more

Are Doctors Responsible for Damages to the Victims of the Opioid Epidemic

by Howard Ankin on

Physicians play a significant role in opioid abuse, addiction, and death by overprescribing painkillers and when injuries occur, they may be held liable for damages. The number of opioid overdoses has soared to record levels...more

Maryland Telehealth Update: RPM, Store and Forward and Looking Ahead

by Baker Ober Health Law on

The Maryland Medicaid telehealth landscape saw some expansion in late 2017. The growth may not go as far as stakeholders desire, but it is movement nonetheless....more

SAMHSA Final Rule Expands Permitted Disclosures of Substance Use Disorder Information to Subcontractors

The Substance Abuse and Mental Health Services Administration (SAMHSA) has issued a final rule (Rule) updating the Confidentiality of Substance Use Disorder Records, 42 CFR part 2 (Part 2), to expand the circumstances under...more

SAMHSA Finalizes Changes to Rules for Disclosure of Substance Abuse Records to Support Health Care Operations

by Reed Smith on

The Substance Abuse and Mental Health Services Administration (SAMHSA) has issued a final rule addressing the disclosure of substance use disorder patient records that is intended to facilitate health care activities while...more

New SAMHSA Rule: Permissible Part 2 Substance Abuse Disclosures to Subcontractors

by Baker Ober Health Law on

On January 3, 2018, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a final rule to revise 42 CFR Part 2, the federal regulations governing confidentiality of certain substance abuse patients'...more

Health Care Weekly Preview from ML Strategies – January 2018 #2

The shutdown countdown feels more real this time. Congress now has four days to hash out a spending deal that avoids a government shutdown. A deal could include any number of legislative priorities. DACA talks were...more

SAMHSA Finalizes Second Round of Changes to Federal Substance Use Disorder Privacy Rule

by Foley & Lardner LLP on

New federal regulations published on January 3, 2018, clarify when lawful holders of substance-use disorder records may use and disclose patient identifying information for payment, health care operations, and audits and...more

SAMHSA Finalizes Additional Changes to the Confidentiality of Substance Use Disorder Patient Records Regulations

by Epstein Becker & Green on

On January 3, 2018, the Substance Abuse and Mental Health Services Administration (“SAMHSA”) published a final rule (“Final Rule”) to further update the Confidentiality of Substance Use Disorder Patient Records regulations...more

Final Rule Clarifies When Substance Abuse Programs Can Disclose Patient Information

by Pepper Hamilton LLP on

A final rule from the Substance Abuse and Mental Health Services Administration establishes requirements for the exchange of patient information between substance abuse treatment programs and their agents and contractors. ...more

SAMHSA Further Revises the Part 2 Drug and Alcohol Abuse Confidentiality Requirements

by Bass, Berry & Sims PLC on

On January 3, 2018, the U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA) issues a final rule to implement modifications to the Confidentiality of Substance Use...more

Further modernizations to rules on confidentiality of substance use disorder patient records on the way

by Bricker & Eckler LLP on

On January 3, 2018, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a Final Rule which results in changes to the federal regulations governing substance use disorder patient records, or so-called...more

“Risk Management Lessons From an Opioid Trial”

The use of opioid medications to treat pain is at a watershed moment in the United States. Over the past three decades, opioids have become a standard and effective component of pain management for many practitioners. They...more

Opioid prescribing and potential liability will impact providers in Ohio and across the nation in 2018

by Bricker & Eckler LLP on

Over the last year, Ohio has enacted and implemented numerous prescribing restrictions on opioid drugs for the management of acute pain in response to the nationwide opioid crisis and the proliferation of prescription...more

Alston & Bird Healthcare Week in Review

by Alston & Bird on

On January 2, 2018, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a final rule entitled, Confidentiality of Substance Use Disorder Patient Records. The final rule makes changes to the SAMHSA...more

Risk, Reward and Pain: Doctor Lessons from An Opioid Trial

Nope. No opioids here. Opioid medications continue to be in the news, as demonstrated by the recent nationwide state attorneys-general investigation. This situation only demands more attention from physicians and other...more

New Substance Use Disorder Confidentiality Final Rules

by Holland & Knight LLP on

The federal Substance Abuse and Mental Health Services Administration (SAHMSA) published a Final Rule on January 3, 2018 making further changes to federal rules governing the confidentiality of substance use disorder patient...more

Opioid Lawsuits | The Fight Against Prescription Pain-Killers

by The Brown Firm on

Addiction to Opioid Narcotic Drugs Spreads Throughout the Nation - Thousands of Americans have been touched by the nationwide crisis of opioid addiction. Opioids are powerful prescription medications intended to give pain...more

177 Results
|
View per page
Page: of 8
Cybersecurity

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.